Excel Sirolimus Eluting Stent
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Excel Sirolimus Eluting Stent, covering 2009-01-26 to 2009-01-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions [Phase 4]